1. Home
  2. SWIN vs ELTX Comparison

SWIN vs ELTX Comparison

Compare SWIN & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • ELTX
  • Stock Information
  • Founded
  • SWIN 2017
  • ELTX 2011
  • Country
  • SWIN Hong Kong
  • ELTX United States
  • Employees
  • SWIN 33
  • ELTX N/A
  • Industry
  • SWIN
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWIN
  • ELTX Health Care
  • Exchange
  • SWIN Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • SWIN 541.0M
  • ELTX 121.7M
  • IPO Year
  • SWIN 2023
  • ELTX N/A
  • Fundamental
  • Price
  • SWIN $2.89
  • ELTX $11.50
  • Analyst Decision
  • SWIN
  • ELTX Strong Buy
  • Analyst Count
  • SWIN 0
  • ELTX 2
  • Target Price
  • SWIN N/A
  • ELTX $11.00
  • AVG Volume (30 Days)
  • SWIN 1.6M
  • ELTX 101.1K
  • Earning Date
  • SWIN 06-30-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • SWIN N/A
  • ELTX N/A
  • EPS Growth
  • SWIN N/A
  • ELTX N/A
  • EPS
  • SWIN N/A
  • ELTX N/A
  • Revenue
  • SWIN $3,316,000.00
  • ELTX N/A
  • Revenue This Year
  • SWIN $29.79
  • ELTX N/A
  • Revenue Next Year
  • SWIN $54.60
  • ELTX N/A
  • P/E Ratio
  • SWIN N/A
  • ELTX N/A
  • Revenue Growth
  • SWIN N/A
  • ELTX N/A
  • 52 Week Low
  • SWIN $1.16
  • ELTX $4.05
  • 52 Week High
  • SWIN $5.09
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 42.29
  • ELTX 56.79
  • Support Level
  • SWIN $2.45
  • ELTX $10.00
  • Resistance Level
  • SWIN $3.10
  • ELTX $11.89
  • Average True Range (ATR)
  • SWIN 0.47
  • ELTX 0.71
  • MACD
  • SWIN -0.05
  • ELTX -0.05
  • Stochastic Oscillator
  • SWIN 21.77
  • ELTX 57.25

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: